Displaying 1 - 1 of 1
| Active Ingredient | MITOMYCIN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Upper gastro-intestinal and breast cancers and by bladder instillation for superficial bladder tumours. |
| Caution | Delayed bone-marrow toxicity , nausea, vomiting and anorexia, stomatitis, leukopenia, thrombocytopenia,alopecia. |
| Dose Range | According to disease and patient particulars. |
| Drug Interactions | |
| Pregnancy | Mitomycin can cause fetal harm in humans. Animal studies have shown delayed feta More ... |
| Breast Feeding | Mitomycin is distributed into breastmilk. Breastfeeding is not recommended durin More ... |